Application 021375

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ALAVERTLORATADINETABLET, ORALLY DISINTEGRATING;ORAL10MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021375-001ALAVERTLORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d4dbc9d85df4…
2026-10-15 13:18:302026-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c2088c7a36db…
2026-09-14 22:38:342026-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1984e616aacf4f…
2026-08-18 06:07:402026-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-194b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-1987673890dc5c…
2021-03-12 10:30 UTC2021-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-195aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-198869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f01610625f2…
2019-09-15 20:21 UTC2019-09N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19b00525d2431f…
2019-07-19 19:46 UTC2019-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-196a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-191c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-199b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193f0d92c62455…
2023-05-13 08:27 UTC2023-05N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-19053a50430f4f…
2023-01-26 05:58 UTC2023-01N021375-001ALAVERT10MGTABLET, ORALLY DISINTEGRATING / ORAL2002-12-193bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 17 of 17 · 338 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LoratadineLORATADINEOhm Laboratories Inc.b83de07d-37f4-42b4-b43e-29173454bef02019-07-17WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEKROGER COMPANY6f7f7005-22db-4b88-9771-e31c21e9b2b12019-05-22WarningsName fallback
generic name: LORATADINE
CHILDRENS LORATADINELORATADINECVS PHARMACY, INCeca96e9e-7e8f-4e8e-8ec6-43c9fee1096c2019-02-26WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINEBionpharma Inc.59bebce3-2b82-4521-a796-2d4c83bcf6692019-01-08WarningsName fallback
generic name: LORATADINE
Allergy ReliefLORATADINEAllegiant Health0991388a-2eb8-4913-9efc-adf411eddf3a2018-11-08WarningsName fallback
generic name: LORATADINE
Loratadine Allergy ReliefLORATADINEDISCOUNT DRUG MART55d3ee36-116b-4ec6-b409-79d67a2b54ae2018-09-14WarningsName fallback
generic name: LORATADINE
Loratadine Allergy ReliefLORATADINEWinCo Foods, LLC506a60e8-7fec-4bb0-babc-204058ae120f2018-08-29WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEValu Merchandisers Company0cd920b4-b15a-4ca9-87e2-4dd523c6d1f82018-08-28WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEChain Drug Marketing Association Inc.b4edf5b1-398d-405a-8a42-76044b31ebb72018-08-27WarningsName fallback
generic name: LORATADINE
CHILDRENS LORATADINELORATADINECVS PHARMACY, INC62e94727-cbb3-4c57-b241-161ab634c6802018-08-03WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINERite Aid11926331-f6b8-4590-9dcd-755a9d9468412018-06-12WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINESMART SENSE (KMART)c2db3398-ead6-4bb6-8aa6-f1366a8461442018-05-16WarningsName fallback
generic name: LORATADINE
LORATADINELORATADINETIME CAP LABORATORIES INC85b26cf3-448c-4d4f-93a2-aa89530ec1f12018-05-16WarningsName fallback
generic name: LORATADINE
Loratadine Allergy ReliefLORATADINEHEB6703e4f3-e9b8-4c70-9085-3d6ac0d7fbda2018-05-14WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEPremier Value778a6979-ea47-4381-8c40-84b3c2325a7e2018-01-11WarningsName fallback
generic name: LORATADINE
Loratadine Allergy ReliefLORATADINELIDL US, LLC11bc027c-d28d-45f0-a4cb-24a3834a69952018-01-09WarningsName fallback
generic name: LORATADINE
AllergyLORATADINESelder, S.A. de C.V.afdb0117-dd2d-4ab1-a2f4-2a88b6bf52512016-12-22WarningsName fallback
generic name: LORATADINE
LoratadineLORATADINEMylan Pharmaceuticals Inc.3b307aea-5a68-4c82-959a-cda4ffbd0a4a2013-11-15WarningsName fallback
generic name: LORATADINE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 8 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0573-2620ALAVERT ALLERGYloratadineGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-2620ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2620ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineGlaxoSmithKline Consumer Healthcare Holdings (US) LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
0573-2621ALAVERT ALLERGYloratadineWyeth Consumer Healthcare LLCNDACurrent
80070-110AlavertLORATADINEFoundation Consumer BrandsNDACurrent
80070-120AlavertLORATADINEFoundation Consumer BrandsNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
27639SUPPL2005-08-23
5224ORIG2004-05-26
42129ORIG2004-03-24
36796ORIG2003-04-09